Shares of Marriott Vacations Worldwide Corp (NYSE:VAC) rose sharply in pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued FY26 adjusted EPS guidance above estimates.

Marriott Vacations posted adjusted EPS of $1.86, beating market estimates of $1.57. The company's quarterly sales came in at $1.323 billion versus estimates of $1.294 billion.

Marriott Vacations shares jumped 12.7% to $65.34 in the pre-market trading session.

Here are some other stocks moving in pre-market trading.

Gainers

• Healthcare Triangle Inc (NASDAQ:HCTI) gained 58.2% to $9.19 in pre-market trading fter the company announced that its subsidiary, QuantumNexis Malaysia, entered into a strategic partnership with TNG Digital.
• Profusa Inc (NASDAQ:PFSA) gained 57.1% to $1.98 in pre-market trading. The company recently announced it received several purchase orders for the Lumee tissue oxygen monitoring system and raised its FY26 revenue guidance.
• Curanex Pharmaceuticals Inc (NASDAQ:CURX) gained 42.1% to $0.45 in pre-market trading. The New York-based pharmaceutical company announced on Wednesday the completion of a Good Manufacturing Practice (GMP)-compliant pilot-scale batch of its lead botanical drug candidate, Phyto-N.
• MDJM Ltd (NASDAQ:UOKA) gained 39.8% to $0.27 in pre-market trading after surging 24% on Wednesday.
• Nutanix Inc (NASDAQ:NTNX) rose 21% to $46.50 in pre-market trading after the company reported better-than-expected second-quarter sales results. Also, the company signed a multi-year agreement with AMD to develop an open, full-stack AI infrastructure platform to power agenic AI applications.
• Sezzle Inc (NASDAQ:SEZL) gained 15.8% to $72.48 in pre-market trading after the company reported better-than-expected fourth-quarter financial results and raised its FY26 adjusted EPS guidance above estimates. Also, the company issued FY26 sales guidance above estimates.
• Red Robin Gourmet Burgers Inc (NASDAQ:RRGB) rose 14.4% to $4.15 in pre-market trading after the company reported better-than-expected quarterly financial results.
• BTQ Technologies Corp (NASDAQ:BTQ) gained 13.2% to $3.69 in pre-market trading after jumping 29% on Wednesday.
• IONQ Inc (NYSE:IONQ) surged 13.2% to $38.04 in pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued FY26 sales guidance above estimates.

Losers

• Matinas BioPharma Holdings Inc (NYSE:MTNB) fell 24.1% to $0.46 in pre-market trading.
• Procept Biorobotics Corp (NASDAQ:PRCT) shares dipped 23.5% to $21.30 in pre-market trading after the company reported worse-than-expected fourth-quarter financial results and cut its FY26 guidance.
• C3.ai Inc (NYSE:AI) dipped 23.5% to $7.89 in pre-market trading after the company reported worse-than-expected third-quarter financial results.
• Array Technologies Inc (NASDAQ:ARRY) fell 23.5% to $8.40 in pre-market trading after the company reported fourth-quarter financial results and issued fY26 adjusted EPS guidance below estimates.
• Energy Recovery Inc (NASDAQ:ERII) fell 19.2% to $13.02 in pre-market trading after the company reported worse-than-expected fourth-quarter financial results and issued FY26 guidance below estimates.
• Trade Desk Inc (NASDAQ:TTD) dipped 16.6% to $20.99 in pre-market trading after the company reported fourth-quarter financial results and issued first-quarter revenue guidance below estimates.
• Goodrx Holdings Inc (NASDAQ:GDRX) tumbled 14.7% to $2.09 in pre-market trading after the company reported fourth-quarter financial results and issued FY26 sales guidance below estimates.
• Innovex International Inc (NYSE:INVX) fell 11.8% to $25.80 in pre-market trading after the company announced pricing of underwritten offering of 5,750,000 shares of common stock by selling stockholders.
• Vir Biotechnology Inc (NASDAQ:VIR) declined 10.8% to $8.92 in pre-market trading as the company announced pricing of public offering of common stock.
• Larimar Therapeutics Inc (NASDAQ:LRMR) fell 9.6% to $5.38 in pre-market trading as the company announced pricing of upsized $100 million underwritten public offering.

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.